Intestinal L-cell mechanoreception regulates hepatic lipid metabolism through GLP-1.
Sci Adv · 2025
Last updated 2026-05-28In mice fed normal or high-fat diets, reducing GLP-1 levels led to increased fat buildup in the liver and higher activity of genes linked to fat production. Giving the GLP-1 drug exendin-4 helped reduce liver fat by boosting a protein called β-catenin and slowing fat creation. Stimulating GLP-1 release through intestinal bead implantation also reduced liver fat in obese mice, but this effect was lost when the mice lacked a specific protein.
AI summary of the abstract below.
| Journal | Sci Adv, 2025 |
|---|---|
| Citations | 5 |
| Relative citation ratio | 1.85 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes, Obesity, Mash |
Abstract
Glucagon-like peptide-1 (GLP-1), secreted by intestinal L cells, is essential for lowering postprandial glucose levels and regulating hepatic lipid metabolism.We investigate the effects of manipulating Piezo1 in L cells on hepatic lipid metabolism. We found that normal and high-fat diet-fed L cell-specific knockout () mice exhibited reduced circulating GLP-1 levels, increased hepatic lipid accumulation, decreased β-catenin expression, and elevated lipogenesis-related genes and proteins, including SREBP1c, PPARγ, FASN, and ACC. Treatment with exendin-4 improved fatty liver in mice by stimulating β-catenin and inhibiting de novo lipogenesis. Intestinal bead implantation stimulated GLP-1 release and inhibited lipid synthesis in livers of diet-induced obese mice but not in mice. In primary hepatocytes derived from mice, lipid accumulation and enhanced fatty acid synthesis were associated with reduced β-catenin expression and impaired nuclear translocation. Exendin-4 treatment alleviated lipid accumulation, which was blocked by the β-catenin inhibitor nitazoxanide. L-cell mechanoreception is vital for regulating hepatic lipid metabolism through GLP-1.
Verbatim abstract via PubMed 40446026 ↗